We’ve created INOFEA from the desire to meet a critical need related to enzyme lack of stability and robustness: the possibility to provide enzymes with resistance to process conditions, so that they could be fully deployed in the health, consumer and processing industry.
Unlike other existing technologies, our innovative nanotechnology platform is capable of shielding sensitive enzymes and has positively demonstrated substantial benefits to customers in a number of health and other industry applications.
Meet us at 3rd European Chemistry Partnering in Frankfurt on February 26, 2019
We are happy to meet you as innovative industry partners at the ECP-event in Frankfurt later in February this year. It is our third participation and we are looking forward to a fruitful day full of interesting discussions on technologies and business opportunities.